Does Pfizer Inc. conduct research and development?

Pfizer Inc. is indeed heavily involved in research and development, which is a critical component of their overall operations. The company is dedicated to discovering and developing innovative therapies and vaccines that address a wide range of medical conditions. Their research efforts focus on several areas, including oncology, immunology, neurosciences, rare diseases, and cardiology, among others. Pfizer employs a substantial number of scientists, researchers, and healthcare professionals who work collaboratively to advance their research initiatives. Pfizer has invested billions of dollars in research and development over the years, recognizing that this investment is essential for the discovery of new pharmaceuticals and biologics that can improve patient outcomes and contribute to public health. The company also frequently engages in partnerships and collaborations with academic institutions, biotechnology companies, and other organizations to leverage external expertise and resources, which helps accelerate the development of new therapies. Additionally, Pfizer is known for its commitment to conducting clinical trials that gather data on the safety and efficacy of their products. These trials are a vital part of the drug development process and ultimately contribute to regulatory submissions for approval. For updated information regarding Pfizer's research and development initiatives, one can visit their official website, where they provide details about current projects and ongoing clinical studies.